Not only do drug prices increase during shortages, but drugs prescribed as substitutes also have higher costs; small business owners have identified the cost of healthcare as the most important issue affecting them; the average enrollee share of premiums for federal employees will increase 1.5% in 2019.
A new study has found that not only do drug prices increase during shortages, but drugs prescribed as substitutes also have higher costs. Forbes reported that drug prices increased 7.3% in the 11 months before shortages and 16% for another 11 months after. The price increases were even higher when the product had 3 or fewer competitors. There were 146 shortages in 2017 and there have been 95 so far in 2018.
A survey has found that small business owners have identified the cost of healthcare as the most important issue affecting them. According to The Hill, 40% chose healthcare costs, which could be important in the upcoming midterm elections. The survey also found that small business owners are politically active, with 77% voting regularly in local elections and 93% voting in national contests. In addition, Democrats have an edge on healthcare issues in the midterms.
While the healthcare plans that cover nearly two-thirds of federal employees and retirees will see decreases in premiums in 2019, the average premium for federal employees will increase 1.5%. The government pays about 70% of premium for federal employees, reported The Washington Post. Federal employees have seen a few years of increases of about 6% to 7%, but lower-than-expected claims rates, renegotiated contracts, and the expansion of telehealth services have helped keep the increase down for 2019. In total, there are 265 plans available to federal employees in 2019.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512